Candida infection, prophylaxis in neutropenic cancer patients at substantial risk
Oncology 1 drugs · 6 brands available in Jordan
Drugs used for Candida infection, prophylaxis in neutropenic cancer patients at substantial risk
| Drug | Class |
|---|---|
| Caspofungin | J02A - Antimycotics for systemic use |
Brands (6)
| Brand | Form / strength | Agent | Citizen (JOD) |
|---|---|---|---|
| Cancidas Vial | Vial 50 mg | Adatco Drug Store | — |
| Cancidas Vial | Vial 70 mg | Adatco Drug Store | — |
| Cangin Powder for Concentrate for Solution for IV Infusion | Infusion 70 mg | MS PHARMA/JORDAN | — |
| Cangin Powder for Concentrate for Solution for IV Infusion | Infusion 50 mg | MS PHARMA/JORDAN | — |
| Candigard | Vial 77.69 equ.to 70 capsofungin mg | Hikma Pharmaceuticals Co.Ltd/Jordan | — |
| Candigard | Vial 55.52 mg | شركة أدوية الحكمة / Hikma Pharmaceuticals / Not Determined | — |